La Jolla Pharmaceutical Company

(LJPC) Trade

By |

Profile

La Jolla Pharmaceutical Co is an American biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.

Contact Information

Website: www.ljpc.com
Email: info@ljpc.com
Main Phone: +1 858 207-4264
Address: 4550 Towne Centre Court
Address 2: 6th Floor
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: George F. Tidmarsh
Employees: 169
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

La Jolla Pharmaceutical Co is an American biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.

Contact Information

Website: www.ljpc.com
Email: info@ljpc.com
Main Phone: +1 858 207-4264
Address: 4550 Towne Centre Court
Address 2: 6th Floor
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: George F. Tidmarsh
Employees: 169
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 9.75 $ -0.15 (-1.52%)
Last Price 9.75 Change $ -0.15 Change % -1.52 Tick N/A
Bid 0. Bid Size 0.00 Ask 0. Ask Size 0.00
Open 10.02 High 10.30 Low 9.74 Prev Close 9.90
Last Trade Volume 725,024 52 Wk Hi 38.39 52 Wk Low 5.01
Market Cap 264.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 27,098,778.00 EPS (TTM) -6.82 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 28
Number of Buys 1 27
Number of Sells 0 1
Net Activity 508474 925474
Last 10 Buys Shares
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Kevin C. Tang 1,000
Last 10 Sell Shares
Laura L. Douglass 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 115 115 115 115
Low Target Price Estimate 23 23 23 23
Mean Target Price Estimate 57.67 57.67 57.67 57.67
Standard Deviation 34.16 34.16 34.16 34.16
Date of Most Recent Estimate 05/16/18 05/16/18 05/16/18 05/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.17 2.17 2.17 2.17